Gregory Renza
Stock Analyst at Truist Financial
(4.84)
# 412
Out of 4,574 analysts
775
Total ratings
54.1%
Success rate
18.5%
Average return
Main Sectors:
Stocks Rated by Gregory Renza
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AGIO Agios Pharmaceuticals | Maintained: Buy | n/a | $36.36 | - | 43 | Jul 22, 2026 | |
| NUVB Nuvation Bio | Maintained: Buy | n/a | $6.42 | - | 27 | Jul 21, 2026 | |
| RVMD Revolution Medicines | Reiterated: Buy | n/a | $189.23 | - | 5 | Jul 10, 2026 | |
| NRIX Nurix Therapeutics | Reiterated: Buy | $32 → $34 | $23.38 | +45.42% | 27 | Jul 10, 2026 | |
| CGON CG Oncology | Maintained: Buy | n/a | $69.32 | - | 20 | Jul 9, 2026 | |
| AMGN Amgen | Maintained: Hold | $327 → $340 | $376.04 | -9.58% | 38 | Jul 7, 2026 | |
| EXEL Exelixis | Maintained: Hold | $54 → $56 | $55.37 | +1.14% | 33 | Jul 7, 2026 | |
| GILD Gilead Sciences | Maintained: Buy | $156 | $129.31 | +20.64% | 15 | Jul 7, 2026 | |
| JAZZ Jazz Pharmaceuticals | Maintained: Buy | $254 | $253.87 | +0.05% | 40 | Jul 7, 2026 | |
| REGN Regeneron Pharmaceuticals | Maintained: Buy | $778 → $769 | $656.01 | +17.22% | 12 | Jul 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $29 → $27 | $19.44 | +38.89% | 32 | Jul 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $416 | $325.90 | +27.65% | 16 | Jul 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $31 | $22.86 | +35.61% | 4 | Jul 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $63 | $35.40 | +77.97% | 32 | Jul 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $135 → $155 | $125.70 | +23.31% | 12 | Jul 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $35 → $38 | $19.27 | +97.20% | 34 | Jun 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $28.87 | - | 3 | Jun 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $17 → $4 | $3.72 | +7.53% | 16 | Jun 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $4.13 | - | 35 | Jun 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $83 | $34.79 | +138.57% | 1 | May 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $2.91 | - | 18 | May 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $8 → $7 | $3.87 | +80.88% | 8 | May 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $51 | $18.29 | +178.84% | 3 | Apr 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $26 | $24.84 | n/a | 57 | May 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $8 | $1.15 | n/a | 24 | May 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $5 | $0.9701 | n/a | 36 | May 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $16 | $6.05 | n/a | 23 | May 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $20 | $5.02 | n/a | 23 | May 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $48 → $46 | $0.6884 | n/a | 8 | May 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $26 | $25.88 | n/a | 31 | May 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $16 | $0.4733 | n/a | 15 | May 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $12 → $13 | $7.87 | n/a | 14 | May 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $38 | $43.08 | n/a | 26 | May 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $2,160 → $180 | $18.44 | n/a | 11 | Jun 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $5 → $80 | $0.632 | n/a | 18 | Mar 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $1 → $15 | $0.031 | n/a | 14 | Nov 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $348 | $202.19 | n/a | 1 | Sep 8, 2015 |
Agios Pharmaceuticals
Jul 22, 2026
Maintained: Buy
Price Target: n/a
Current: $36.36
Upside: -
Nuvation Bio
Jul 21, 2026
Maintained: Buy
Price Target: n/a
Current: $6.42
Upside: -
Revolution Medicines
Jul 10, 2026
Reiterated: Buy
Price Target: n/a
Current: $189.23
Upside: -
Nurix Therapeutics
Jul 10, 2026
Reiterated: Buy
Price Target: $32 → $34
Current: $23.38
Upside: +45.42%
CG Oncology
Jul 9, 2026
Maintained: Buy
Price Target: n/a
Current: $69.32
Upside: -
Amgen
Jul 7, 2026
Maintained: Hold
Price Target: $327 → $340
Current: $376.04
Upside: -9.58%
Exelixis
Jul 7, 2026
Maintained: Hold
Price Target: $54 → $56
Current: $55.37
Upside: +1.14%
Gilead Sciences
Jul 7, 2026
Maintained: Buy
Price Target: $156
Current: $129.31
Upside: +20.64%
Jazz Pharmaceuticals
Jul 7, 2026
Maintained: Buy
Price Target: $254
Current: $253.87
Upside: +0.05%
Regeneron Pharmaceuticals
Jul 7, 2026
Maintained: Buy
Price Target: $778 → $769
Current: $656.01
Upside: +17.22%
Jul 7, 2026
Maintained: Buy
Price Target: $29 → $27
Current: $19.44
Upside: +38.89%
Jul 7, 2026
Maintained: Buy
Price Target: $416
Current: $325.90
Upside: +27.65%
Jul 7, 2026
Maintained: Buy
Price Target: $31
Current: $22.86
Upside: +35.61%
Jul 7, 2026
Maintained: Buy
Price Target: $63
Current: $35.40
Upside: +77.97%
Jul 2, 2026
Maintained: Buy
Price Target: $135 → $155
Current: $125.70
Upside: +23.31%
Jun 30, 2026
Maintained: Buy
Price Target: $35 → $38
Current: $19.27
Upside: +97.20%
Jun 30, 2026
Maintained: Buy
Price Target: n/a
Current: $28.87
Upside: -
Jun 2, 2026
Downgraded: Hold
Price Target: $17 → $4
Current: $3.72
Upside: +7.53%
Jun 1, 2026
Maintained: Buy
Price Target: n/a
Current: $4.13
Upside: -
May 27, 2026
Initiated Coverage: Buy
Price Target: $83
Current: $34.79
Upside: +138.57%
May 12, 2026
Maintained: Buy
Price Target: n/a
Current: $2.91
Upside: -
May 1, 2026
Maintained: Hold
Price Target: $8 → $7
Current: $3.87
Upside: +80.88%
Apr 24, 2026
Maintained: Buy
Price Target: $51
Current: $18.29
Upside: +178.84%
May 19, 2025
Reiterated: Buy
Price Target: $26
Current: $24.84
Upside: n/a
May 14, 2025
Maintained: Buy
Price Target: $8
Current: $1.15
Upside: n/a
May 13, 2025
Maintained: Hold
Price Target: $5
Current: $0.9701
Upside: n/a
May 13, 2025
Reiterated: Buy
Price Target: $16
Current: $6.05
Upside: n/a
May 13, 2025
Maintained: Hold
Price Target: $20
Current: $5.02
Upside: n/a
May 12, 2025
Maintained: Buy
Price Target: $48 → $46
Current: $0.6884
Upside: n/a
May 8, 2025
Maintained: Hold
Price Target: $26
Current: $25.88
Upside: n/a
May 7, 2025
Maintained: Buy
Price Target: $16
Current: $0.4733
Upside: n/a
May 6, 2025
Maintained: Buy
Price Target: $12 → $13
Current: $7.87
Upside: n/a
May 6, 2025
Maintained: Hold
Price Target: $38
Current: $43.08
Upside: n/a
Jun 26, 2023
Downgraded: Hold
Price Target: $2,160 → $180
Current: $18.44
Upside: n/a
Mar 16, 2022
Maintained: Hold
Price Target: $5 → $80
Current: $0.632
Upside: n/a
Nov 12, 2021
Maintained: Hold
Price Target: $1 → $15
Current: $0.031
Upside: n/a
Sep 8, 2015
Rated: Buy
Price Target: $348
Current: $202.19
Upside: n/a